The legal status of one peptide or GLP-1 drug in the United States (FDA), Australia (TGA), the UK (MHRA), the EU (EMA), Canada (Health Canada), Brazil (ANVISA, where covered) and sport (WADA), or in the one place you name. Returns each status with a plain-language note; for the U.S. also the full answer (compounding rules, the latest FDA advisory vote, the next dated event), plus primary sources and the date it was last verified.